IRIS - Res&Arch Institutional Research Information System - Research & Archive

GRESELE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.146
EU - Europa 7.017
AS - Asia 3.400
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 6
SA - Sud America 6
OC - Oceania 4
Totale 19.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.112
IE - Irlanda 1.680
UA - Ucraina 1.643
HK - Hong Kong 1.192
IT - Italia 1.127
SG - Singapore 1.045
SE - Svezia 767
VN - Vietnam 469
DE - Germania 429
FI - Finlandia 407
RU - Federazione Russa 386
CN - Cina 350
TR - Turchia 192
GB - Regno Unito 151
FR - Francia 149
KR - Corea 68
CH - Svizzera 56
BE - Belgio 40
NL - Olanda 30
PL - Polonia 30
CA - Canada 27
AT - Austria 26
UZ - Uzbekistan 26
LB - Libano 21
CZ - Repubblica Ceca 18
GR - Grecia 18
ES - Italia 14
EU - Europa 13
MK - Macedonia 11
RO - Romania 11
IN - India 8
BG - Bulgaria 6
PH - Filippine 6
IR - Iran 5
LT - Lituania 5
MX - Messico 5
JP - Giappone 4
RS - Serbia 4
NO - Norvegia 3
PY - Paraguay 3
ZA - Sudafrica 3
AU - Australia 2
CL - Cile 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
ID - Indonesia 1
IS - Islanda 1
KZ - Kazakistan 1
MA - Marocco 1
SA - Arabia Saudita 1
Totale 19.593
Salva come PNG Salva come JPEG
Città #
Chandler 1.785
Dublin 1.670
Hong Kong 1.189
San Mateo 908
Jacksonville 903
Singapore 810
Boardman 533
Dong Ket 467
Santa Clara 447
Altamura 436
Medford 417
Princeton 416
Lawrence 313
Wilmington 291
Perugia 289
Ann Arbor 265
Des Moines 226
Andover 212
Izmir 191
Saint Petersburg 139
Beijing 136
Ashburn 94
Norwalk 77
Helsinki 75
Los Angeles 69
Redmond 55
Dearborn 54
Woodbridge 52
Seoul 49
Munich 48
San Paolo di Civitate 46
Brussels 39
Rome 38
Shanghai 36
New York 31
Moscow 27
San Diego 26
Houston 22
Dallas 19
Den Haag 19
Falls Church 16
Milan 14
Amelia 13
Auburn Hills 13
Chicago 12
Narni 11
London 10
Ottawa 10
Collazzone 9
Olomouc 9
Redwood City 9
Valencia 9
Frankfurt Am Main 8
Kraków 8
Lappeenranta 8
Timisoara 8
Toronto 8
Philadelphia 7
Pisa 7
Kiev 6
Lausanne 6
Nürnberg 6
Simi Valley 6
Espoo 5
Paris 5
Tappahannock 5
Vienna 5
Florence 4
Genoa 4
Homburg 4
Madrid 4
Sofia 4
Termoli 4
Alameda 3
Breia 3
Favara 3
Fernando De La Mora 3
Frankfurt am Main 3
Kunming 3
La Spezia 3
Menlo Park 3
Padova 3
Parma 3
Phoenix 3
Pune 3
Skopje 3
Southwark 3
Zhengzhou 3
Amsterdam 2
Ancona 2
Andria 2
Bardovci 2
Bishkek 2
Bratislava 2
Bucharest 2
Calgary 2
Campobasso 2
Casalbordino 2
Castagnola 2
Ciampino 2
Totale 13.245
Salva come PNG Salva come JPEG
Nome #
Fisiopatologia dell'emostasi 511
PIASTRINE TRASFETTATE CON MATERIALE GENETICO ESOGENO E MICROPARTICELLE DERIVATE DA DETTE PIASTRINE TRASFETTATE, METODO PER LA LORO PREPARAZIONE E LORO USI. 190
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 129
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 118
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 112
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 107
Impact of Chronic Antiplatelet Therapy prior to Hospitalization on Ischemic and Bleeding Events in Invasively Managed Patients with Acute Coronary Syndromes: The ACUITY Trial 104
Albumin prevents TxB2 formation from thrombin-stimulated human platelets by sequestring the liberated arachidonic acid in the extracellular space 99
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 95
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 91
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia. 88
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 88
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 88
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 88
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 86
Tardive gestosis: clinical observations. 86
Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. 85
Nitric oxide and its antithrombotic action on the cardiovascular system 83
Platelets are essential for leukocyte recruitment in allergic inflammation. 83
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 82
C-reactive protein induces expression of matrix metalloproteinase-9: A possible link between inflammation and plaque rupture. 81
A novel congenital dysprothrombinemia leading to defective prothrombin maturation. 79
[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention]. 78
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 78
Guida alla terapia antitrombotica curata dalla Federazione Nazionale Centri per la Diagnosi della Trombosi e la Sorveglianza delle Terapie Antitrombotiche (FCSA) 78
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 77
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 75
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 75
Diagnosis of platelet-type von Willebrand disease by flow cytometry. 75
Beta 1-tubulin in human platelets: not simply a structural cell frame. 75
Acquired von Willebrand syndrome type 2A in a JAK2-positive essential thrombocythaemia-affected member of a large von Willebrand disease family with a novel autosomal dominant A1716P mutation. 74
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 74
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 73
Arterite temporale occulta: contributo casistico e revisione della letteratura 73
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. 73
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 73
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 73
Cytoskeletal perturbation leads to platelet dysfunction and thrombocytopenia in variant forms of Glanzmann thrombasthenia 73
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 72
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 71
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. 71
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 71
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. 71
Heparin in the prophylaxis and treatment of venous thromboembolism and other thrombotic diseases. 71
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. 71
Platelets 70
Farmaci antitrombossano sintetasi ed antagonisti dei recettori per il trombossano. 70
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 70
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 69
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 69
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 68
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 68
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 67
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 67
Anti-platelet therapy: phosphodiesterase inhibitors. 67
Antiplatelet agents in clinical practice and their haemorrhagic risk. 67
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 67
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 67
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 66
Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events. 66
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 65
Effects of resveratrol and other wine polyphenols on vascular function: an update. 65
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 65
Matrix metalloproteinases and peripheral arterial disease. 64
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 64
Acetylsalicylic acid, BM 13.177 and picotamide improve the survival of endotoxin-infused rabbits 64
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. 64
Antithrombotic potential of thromboxane synthase inhibitors: problems and possible solutions 64
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 64
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 63
Kidney failure and endothelial disfunction: effects of haemodialysis 62
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. 62
Effect of different plasma expanders on erythrocyte filterability 62
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 61
In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression: a marker of platelet activation 61
Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2. 61
Effect of substituted stilbenes on platelet function 61
Allergen induces the migration of platelets to lung tissue in allergic asthma. 61
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 61
Comparative evaluation of the fully automated HemosIL®AcuStar ADAMTS13 activity assay vs. ELISA: Possible interference by autoantibodies different from anti ADAMTS-13 61
I peptidil leucotrieni regolano la secrezione di pepsinogeno e la mobilitazione del calcio nelle cellule principali isolate 60
Case Report: Sequestro polmonare in un paziente con emofilia a grave HIV positivo. 60
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 60
Splenic irradiation versus splenectomy for severe, refractory HIV-related thrombocytopenia: Effects on platelet counts and immunological status 59
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 59
Incomplete inhibition of platelet function as assessed by the platelet function analyzer (PFA-100) identifies a subset of cardiovascular patients with high residual platelet response while on aspirin. 59
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 59
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 58
Impact of prior chronic antiplatelet therapy on short- and long-term adverse events in patients presenting with an acute coronary syndrome: insights from the ACUITY trial. 58
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 58
Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH 58
Cholinephosphotransferase activity in human platelet 58
Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH. 58
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 58
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 57
Inherited disorders and gene regulation of platelet signal transduction: the picture is expanding. 57
Critical limb ischemia. 57
A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of ITGB3: evidence of a dominant effect of gain-of-function mutations. 57
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia. 57
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 57
Totale 7.705
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020923 0 0 0 0 0 53 271 28 299 138 36 98
2020/20213.403 28 255 90 254 1.009 135 279 28 397 110 300 518
2021/20223.202 75 631 79 129 104 22 37 1.001 43 113 417 551
2022/20235.971 463 1.155 97 451 461 684 6 253 2.131 19 161 90
2023/20242.650 138 203 121 41 29 13 1.019 52 220 99 413 302
2024/20251.861 55 557 145 195 685 224 0 0 0 0 0 0
Totale 20.374